• 1
    Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996;11:16371.
  • 2
    Cowan DT, Wilson-Barnett J, Griffiths P, et al. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 2005;6:11321.
  • 3
    Tennant FS Jr, Uelmen GF. Narcotic maintenance for chronic pain. Medical and legal guidelines. Narc Maintenance 1983;73:8194.
  • 4
    Tennant F, Robinson D, Sagherian A, Seecof R. Chronic opioid treatment of intractable, nonmalignant pain. Pain Manage 1988;Jan/Feb:1826.
  • 5
    Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins JD, eds. Narcotic Analgesics in Anesthesiology. Baltimore, MD: Williams & Wilkins; 1982:199208.
  • 6
    Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990;5:4662.
  • 7
    Tennant FS, Robinson D, Sagherian A, et al. Chronic opioid treatment of intractable, nonmalignant pain. NIDA Res Monogr 1988;81:17480.
  • 8
    Schaffer-Vargas G, Schaffer S, Mejia A, Fernandez C. Opioid for non-malignant pain experience of Venezuelan Center, 9th World Congress on Pain. 1999;289:345.
  • 9
    Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:1916.
  • 10
    Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:6977.
  • 11
    Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001;2:197204.
  • 12
    Moulin DE, Iezzi A, Amireh R, et al. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:1437.
  • 13
    Porter J, Jick HN. Addiction rare in patients treated with narcotics. N Engl J Med 1980; 302:123.
  • 14
    Doquang-Cantagrel N, Magnuson SK, Wallace MS. Tolerability and efficacy of opioids in chronic nonmalignant pain. Addiction 1991; 722:129.
  • 15
    Bouckoms AJ, Masand P, Murray GB, et al. Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychiatry 1992;8:18592.
  • 16
    Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591600.
  • 17
    France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:137982.
  • 18
    Kell MJ. Long-term methadone maintenance for intractable, nonmalignant pain: Pain control and plasma opioid levels. AJPM 1994;4:106.
  • 19
    Cowan DT, Wilson-Barnett J, Griffiths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med 2003; 4:34051.
  • 20
    Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: A comparative trial. Clin Ther 2001;23:142944.
  • 21
    Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: A double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:4.
  • 22
    Kjaersgaard-Andersen P, Nafei A, Skov O, et al. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomized, double-blind, multi-centre study. Pain 1990;43:30918.
  • 23
    Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004;112:37280.
  • 24
    Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:304352.
  • 25
    Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006;3:CD006146.
  • 26
    Furlan A, Sandoval J, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006;174:158994.
  • 27
    Martell BA, O’Connor PG, Kerns RD, et al. Systemic review: Opioid treatment for chronic back pain; prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:11627.
  • 28
    Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic nonmalignant pain. Curr Med Res Opin 2005;21:155568.
  • 29
    Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil 2005;84:S4255.
  • 30
    Nicolas MK, Molloy AR, Brooker C. Using opioids with persisting noncancer pain: A biopsychosocial perspective. Clin J Pain 2006;22:13746.
  • 31
    Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992;8:7785.
  • 32
    Portenoy R. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11:20317.
  • 33
    Aronoff G. Opioids in chronic pain management: Is there a significant risk of addiction? Curr Rev Pain 2000;4:11221.
  • 34
    Wasan A, Correll D, Kissin I, O’Shea S, Jamison R. Iatrogenic addiction in patients treated for acute or subacute pain: A systematic review. J Opioid Manage 2006;2:1622.
  • 35
    Bartleson JD. Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: A review. Pain Med 2002;3:26071.
  • 36
    Jaffee J. Opiates: Clinical aspects. In: Lowenson J, Ruiz P, Mullman R, eds. Substance Abuse, A Comprehensive Text. Baltimore, MD: Williams & Wilkins; 1992:18694.
  • 37
    Passik SD, Kirsh KL, Whitcomb L, et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the pain assessment and documentation tool. J Opioid Manage 2005;1:5.
  • 38
    Chabal C, Erjavec M, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain 1997;13:1505.
  • 39
    Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CE. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: An evaluation of patterns and trends. J Ky Med Assoc 2005;103:5562.
  • 40
    Vaglienti RM, Huber SJ, Noel KR, Johnstone RE. Misuse of prescribed controlled substances defined by urinalysis. W V Med J 2003;99:6770.
  • 41
    Schulzeck S, Gleim M, Maier C. Factors contributing to the results of long-term treatment with oral morphine tablets in patients with chronic non-malignant pain. Anaesthetist 1993;42:54556.
  • 42
    Kell M. Monitoring compliance with OxyContin Rx in 14,712 patients treated in 127 outpatient pain centers. Pain Med 2005;6:1867.
  • 43
    Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003;97:1097102.
  • 44
    Belgrade MJ, Ismail M, Yoon M, Panopoulos G. Non-compliant drug screens during opioid maintenance analgesia for chronic non-malignant pain. Am Pain Society Meeting, 2001. San Diego A♯ 787, p. 42.
  • 45
    Chapman C, Hill H. Prolonged morphine self-administration and addiction liability. Evaluation of two theories in a bone marrow transplant unit. Cancer 1989;63:163644.
  • 46
    Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:18426.
  • 47
    Rangel-Guerra R. An open evaluation of oral butorphanol as long-term therapy in out-patients suffering from moderate to severe chronic pain. J Int Med Res 1981;9:1203.
  • 48
    Manchikanti L, Vidyasagar P, Damron K, et al. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001;4:35865.
  • 49
    Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006;6:46.
  • 50
    Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain. Report of 38 cases. Pain 1986;25:17186.
  • 51
    Dellemijn PLI, van Duijn H, Vanneste JAL. Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 1998;16:2209.
  • 52
    Burchman SL, Pagel PS. Implementation of a formal treatment agreement for outpatient management of chronic nonmalignant pain with opioid analgesics. J Pain Symptom Manage 1995;10:55663.
  • 53
    Arkinstall W, Sandler A, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial. Pain 1995;62:16978.
  • 54
    Broughton AN, Gordon DN, Miller AJ. Long term tolerability of cr oxycodone (OxyContin tablets) in 101 patients treated for 12 months. World Congress On Pain, 1999, 339.
  • 55
    Simpson RK Jr, Edmondson EA, Constant CF, Collier C. Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage 1997;14:21824.
  • 56
    Wan Lu C, Urban B, France RD. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1988;19:137982.
  • 57
    Portenoy RK. Chronic opioid therapy for nonmalignant pain: From models to practice. APS J 1992;1:2858.
  • 58
    Kell MJ, Musselman DL. Methadone prophylaxis of intractable headaches: Pain control and serum opioid levels. AJPM 1993;3:714.
  • 59
    Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998;41:160312.
  • 60
    Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:17.
  • 61
    Cowan DT, Allan L, Griffiths P. A pilot study into the problematic use of opioid analgesics in chronic non-cancer pain patients. Int J Nurs Stud 2002; 39:5969.
  • 62
    McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain. A one year study. Am J Ther 2005;12:10612.
  • 63
    Chao J. Retrospective analysis of Kadian (morphine sulfate sustained-release capsules) in patients with chronic, nonmalignant pain. Pain Med 2005;6:2625.
  • 64
    Matsumoto A, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:35766.
  • 65
    Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Med 2005;6:43242.
  • 66
    Richarz A, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain. Spine 2005;30:248490.
  • 67
    Watson C, Peter N, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:183741.
  • 68
    Roth SH, Fleischman RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Arch Intern Med 2000;160:85360.
  • 69
    Markenson JA, Zhang CJ, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:52435.
  • 70
    Gimbel JS, Richards P, Portenoy RK Controlled-release oxycodone for pain in diabetic neuropathy. A randomized controlled trial. Neurology 2003;60:92734.
  • 71
    Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2002;59:101521.
  • 72
    Huse E, Larbig W, flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90:4755.
  • 73
    Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998;15:18594.
  • 74
    Quang-Cantagrel Nathalie D, Wallace MS, Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart Review. Anesth Analg 2000;90:9337.
  • 75
    Schofferman J. Long-term opioid analgesic therapy for severe refractory lumbar spine pain. Clin J Pain 1999;15:13640.
  • 76
    Salzman RT, Brobyn RD. Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis. Pharmacology 1983;27(suppl 1):5564.
  • 77
    Peloso PM, Bellamy N, Bensen W, et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000;27:3.
  • 78
    Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: A randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001;91:2331.
  • 79
    Palangio M, Damask MJ, Morris E, et al. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain. Clin Ther 2000;22:87992.
  • 80
    Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain. Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:27891.
  • 81
    Mystakidou D, Parpa E, Tsilika E, et al. Long-term management of noncancer pain with transdermal therapeutic system––Fentanyl. J Pain 2003;4:298306.
  • 82
    Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:718.
  • 83
    Zimmerman M, Waap I. Individual aspects of the quality of life of patients with chronic pain. Observational study of treatment with fentanyl-TTS. MMW Fortschr Med 2005;147(suppl 1):3340.
  • 84
    Manchikanti L, Manchukonda R, Pampati V, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006;9:1239.
  • 85
    Rowbotham MC, Twilling L, Davies P, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:122332.
  • 86
    Parr G, Darekar B, Fletcher A, Bulpitt C. Joint pain and quality of life: Results of a randomized trial. Br J Clin Pharmacol 1989;27:23542.
  • 87
    Rhodin A, Gronbladh L, Nilsson LH, Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence—A long-term follow-up. Eur J Pain 2006;10:2718.
  • 88
    Adams EH, Chwiecko P, Ace-Wagoner Y, et al. A study of Avinza® (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions––The ACCPT Study. Pain Pract 2006;6:25464.
  • 89
    Michna EJ, Ross EL, Janfaza D, et al. Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain 2007;23:1739.
  • 90
    Institute of Medicine Committee to advise Public Health Service on Clinical Practice. Clinical Practice Guidelines Directions for a New Program. Washington, DC: National Academy Press; 1990.
  • 91
    Hoogendoorn WE, van Poppel MN, Bongers PM et al. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 2000;25:211425.
  • 92
    De Vet H, de Bie R, vender Heijden G, et al. Systematic reviews on the basis of methodological criteria. Physiotherapy 1997;83:2849.
  • 93
    Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: A systematic review. Pain 1998;77:113.
  • 94
    Kirsh K, Whitcomb L, Donaghy K, Passik S. Abuse and addiction issues in medically ill patients with pain: Attempts at clarification of terms and empirical study. Clin J Pain 2002;18:S5260.
  • 95
    Cowan D. Problematic terminology for problematic drug use. J Opioid Manage 2006;2:2330.
  • 96
    Fishbain DA. Chronic pain and addiction, chapter 10. In: Boswell MV, Cole BE, eds. Weiner’s Pain Management, A Practical Guide for Clinicians, 7th edition. Boca Raton, FL: CRC Press; 2006:11739.
  • 97
    Li V, Katragadda R, Mosuro Y, Friedman R. Pain and addiction: Screening patients at risk. Pain Med 2001;2:244,A216.
  • 98
    Sees K, DiMarino M, Ruediger N, Sweeney C, Shiffman S. Non-medical use of OxyContin tablets in the United States. J Pain Palliat Care Pharmacother 2005;19:1323.
  • 99
    Smith M, Woody G. Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: Patterns, user characteristics, and management options. Curr Psychiatry Rep 2005;7:33743.
  • 100
    Nurnberger J, Foroud T, Flury L, et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 2001;158:71824.
  • 101
    Passik S, Kirsh K, Whitcomb L, Dickerson P, Theobald D. Pain clinicians’ rankings of aberrant drug-taking behaviors. J Pain Palliative Care 2002;16:3949.
  • 102
    Weissman DE, Haddox JD. Opioid pseudoaddiction: An iatrogenic syndrome. Pain 1989;36:3636.
  • 103
    Ferrari A, Cicero AF, Bertolini A, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: A comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalgia 2006;26:18793.
  • 104
    Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage 2004;27:15669.
  • 105
    Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002;18(4 suppl): S7682.
  • 106
    Lusher J, Elander J, Bevan D, Telfer P, Burton B. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain 2006;22:31624.